CLINICAL, PARACLINICAL CHARACTERISTICS AND ANTIBIOTIC SUSCEPTIBILITY OF AEROMONAS HYDROPHILA CAUSING SEPTICEMIA AT THE NATIONAL HOSPITAL OF TROPICAL DISEASES

Sỹ Tùng Lưu, Đình Tráng Văn, Thị Diệu Ngân Tạ

Main Article Content

Abstract

Objectif: To describe the clinical, paraclinical characteristics and antibiotic susceptibility of Aeromonas hydrophila causing septicemia at the National Hospital of Tropical Diseases. Methods: Cross-sectional, retrospective study of all patients diagnosed with septicemia caused by Aeromonas hydrophila during period 2018 to 2024. Result: 37 patients were enrolled in the study, 27 of which was males (73%), cirrhosis was the underlying disease with the highest rate (67.5%). Clinical manifestations were diverse: 43.2% had skin and soft tissue infections, mainly blisters with bleeding on the lower legs; 83.7% had organ failure, of which most had failure of more than 2 organs (64.8%). The rate of septic shock was 35.1%, the overall fatality rate was 29.7%. Over 90% of isolated bacterial strains were sensitive to ceftriaxone, cefepime, ciprofloxacin and carbapenem groups. The sensitivity rate to ceftazidime, amikacin and levofloxacin was just over 80%. Aeromonas hydrophila were resistant to ampicillin (80.6%), ampicillin/sulbactam (40.6%), and piperacillin/tazobactam (18.9%). Conclusion: A. hydrophila septicemia is uncommon, but can cause notable rates of morbidity and mortality. It is important to have a suspicion of A. hydrophila infection in cirrhosis patients with fever and blisters with bleeding on the lower legs at initial presentation. Prompt diagnosis and early treatment with effective antibiotics are vital.

Article Details

References

1. Ko WC, Lee HC, Chuang YC, Liu CC, Wu JJ. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia. The Journal of infection. May 2000;40(3):267-73. doi:10.1053/jinf.2000.0654
2. Tsai YH, Shen SH, Yang TY, Chen PH, Huang KC, Lee MS. Monomicrobial Necrotizing Fasciitis Caused by Aeromonas hydrophila and Klebsiella pneumoniae. Medical principles and practice : international journal of the Kuwait University, Health Science Centre. 2015;24(5):416-23. doi:10.1159/000431094
3. Wu CJ, Lee HC, Chang TT, et al. Aeromonas spontaneous bacterial peritonitis: a highly fatal infectious disease in patients with advanced liver cirrhosis. Journal of the Formosan Medical Association = Taiwan yi zhi. Apr 2009; 108 (4): 293-300. doi:10.1016/s0929-6646 (09)60069-3
4. Monaghan SF, Anjaria D, Mohr A, Livingston DH. Necrotizing fasciitis and sepsis caused by Aeromonas hydrophila after crush injury of the lower extremity. Surgical infections. Aug 2008; 9(4): 459-67. doi:10.1089/sur.2007.028
5. Patel KM, Svestka M, Sinkin J, Ruff Pt. Ciprofloxacin-resistant Aeromonas hydrophila infection following leech therapy: a case report and review of the literature. Journal of plastic, reconstructive & aesthetic surgery : JPRAS. Jan 2013; 66(1):e20-2. doi:10.1016/ j.bjps.2012.10.002
6. Dumančić J, Čupić M, Potočnjak I, Trbušić M, Degoricija V. The effectiveness of synthetic glucocorticoids on the disease course, treatment, and outcome of severe sepsis and septic shock. Endocrine Oncology and Metabolism. 03/15 2016;2:72-81. doi:10.21040/eom/2016.2.8
7. Tang HJ, Lai CC, Lin HL, Chao CM. Clinical manifestations of bacteremia caused by Aeromonas species in southern Taiwan. PloS one. 2014;9(3):e91642. doi:10.1371/journal.pone.0091642
8. Kaki R. A retrospective study of Aeromonas hydrophila infections at a university tertiary hospital in Saudi Arabia. BMC infectious diseases. Oct 9 2023;23(1):671. doi:10.1186/s12879-023-08660-8
9. Chuang HC, Ho YH, Lay CJ, Wang LS, Tsai YS, Tsai CC. Different clinical characteristics among Aeromonas hydrophila, Aeromonas veronii biovar sobria and Aeromonas caviae monomicrobial bacteremia. Journal of Korean medical science. Nov 2011;26(11):1415-20. doi:10.3346/jkms.2011.26.11.1415
10. Rhee JY, Jung DS, Peck KR. Clinical and Therapeutic Implications of Aeromonas Bacteremia: 14 Years Nation-Wide Experiences in Korea. Infection & chemotherapy. Dec 2016;48(4):274-284. doi:10.3947/ic.2016.48.4.274